Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» antibodies
antibodies
Eli Lilly scores FDA nod for COVID-19 antibody cocktail, aims to make 1M doses by midyear
Fierce Pharma
Wed, 02/10/21 - 10:16 am
Eli Lilly
COVID-19
antibodies
FDA
Emergency Use Authorization
Bristol Myers makes late play for COVID-19 antibody space, picking up 2 early-phase molecules from Rockefeller
Fierce Biotech
Wed, 02/3/21 - 10:56 am
Bristol-Myers Squibb
antibodies
COVID-19
Regeneron COVID-19 drug cocktail combats South Africa variant, Lilly's does not - study
Reuters
Wed, 01/27/21 - 08:06 pm
Regeneron
Eli Lilly
antibodies
COVID-19
Regeneron says monoclonal antibodies prevent Covid-19 in study
Stat
Tue, 01/26/21 - 11:34 am
Regeneron
antibodies
COVID-19
Lilly antibody combo slashed COVID-19 deaths, hospitalizations in high-risk patients
Fierce Pharma
Tue, 01/26/21 - 11:29 am
Eli Lilly
antibodies
COVID-19
US to pay up to $2.6B for more doses of Regeneron's COVID-19 antibody drug
BioPharma Dive
Wed, 01/13/21 - 11:34 pm
Regeneron
COVID-19
antibodies
government contracts
Celltrion's COVID-19 antibody improves outcomes in phase 2
Fierce Biotech
Wed, 01/13/21 - 10:48 am
Celltrion
COVID-19
antibodies
clinical trials
Regeneron says it will continue trial of COVID antibody cocktail as latest data show positive results
Marketwatch
Wed, 12/30/20 - 10:42 am
Regeneron
COVID-19
antibodies
GlaxoSmithKline, Vir look to succeed where Lilly failed with NIH antibody study in hospitalized Covid-19 patients
Endpoints
Thu, 12/17/20 - 06:25 pm
GSK
Vir Biotechnology
Eli Lilly
antibodies
NIH
COVID-19
clinical trials
Lilly and Regeneron COVID-19 antibodies are available all over the U.S. Why aren't they getting to more patients?
Fierce Pharma
Thu, 12/17/20 - 06:19 pm
FDA
Eli Lilly
Regeneron
antibodies
COVID-19
AbbVie pulls the trigger on a Covid-19 antibody, going all in on a drug discovered by research alliance
Endpoints
Mon, 12/14/20 - 11:04 pm
AbbVie
COVID-19
antibodies
Gottlieb op-ed: Manufacturers need to ramp up production of antibodies as 'Covid insurance policy'
Endpoints
Mon, 12/14/20 - 11:01 am
Scott Gottlieb
vaccines
antibodies
COVID-19
AbCellera, tapped by Lilly for its COVID-19 antibody therapy, sets IPO terms with $5B valuation
Fierce Biotech
Mon, 12/7/20 - 10:37 am
AbCellera
Eli Lilly
R&D
Canada
COVID-19
antibodies
IPOs
Eli Lilly announces 650,000 additional doses of bamlanivimab purchased by US government to treat Covid-19
Pharmaceutical Business Review
Thu, 12/3/20 - 10:51 am
Eli Lilly
antibodies
bamlanivimab
COVID-19
government contract
Regeneron, UPenn to use gene therapy tools to deliver a COVID-19 antibody drug
BioPharma Dive
Tue, 12/1/20 - 11:32 pm
Regeneron
antibodies
gene therapy
COVID-19
Twist Bioscience's COVID-19 'nanobodies,' inspired by llamas, show promise in hamsters
Fierce Biotech
Tue, 11/24/20 - 10:36 am
Twist Biosciences
nanobodies
antibodies
llamas
animal studiens
COVID-19
Regeneron COVID-19 drug, used to treat Trump, cleared for emergency use
BioPharma Dive
Sun, 11/22/20 - 11:57 pm
Regeneron
FDA
COVID-19
Emergency Use Authorization
antibodies
Adagio's COVID-19 antibody protects mice and zaps related viruses in lab tests
Fierce Biotech
Fri, 11/20/20 - 11:11 am
Adagio Therapeutics
antibodies
COVID-19
How Effective Will Lilly’s Bamlanivimab be in the Battle Against COVID-19?
BioSpace
Mon, 11/16/20 - 10:08 am
Eli Lilly
bamlanivimab
LY-CoV555
COVID-19
antibodies
Shortage of monkeys slowed down Eli Lilly's Covid-19 antibody partner. And it's a problem for everyone
Endpoints
Fri, 11/13/20 - 12:59 pm
COVID-19
animal studies
clinical trials
antibodies
Eli Lilly
Shanghai Junshi Biosciences
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
next ›
last »